Literature DB >> 26589726

Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.

David C P Cobben1, Hans C J de Boer2, Rob H Tijssen2, Emma G G M Rutten2, Marco van Vulpen2, Jurgen Peerlings3, Esther G C Troost3,4,5,6, Aswin L Hoffmann3,4,5,6, Astrid L H M W van Lier2.   

Abstract

Magnetic resonance imaging (MRI) provides excellent soft-tissue contrast and allows for specific scanning sequences to optimize differentiation between various tissue types and properties. Moreover, it offers the potential for real-time motion imaging. This makes magnetic resonance imaging an ideal candidate imaging modality for radiation treatment planning in lung cancer. Although the number of clinical research protocols for the application of magnetic resonance imaging for lung cancer treatment is increasing (www.clinicaltrials.gov) and the magnetic resonance imaging sequences are becoming faster, there are still some technical challenges. This review describes the opportunities and challenges of magnetic resonance imaging for radiation treatment planning in lung cancer.
© The Author(s) 2015.

Entities:  

Keywords:  MRI; lung cancer; radiation treatment planning

Mesh:

Year:  2015        PMID: 26589726     DOI: 10.1177/1533034615615249

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  3 in total

1.  Feasibility of free breathing Lung MRI for Radiotherapy using non-Cartesian k-space acquisition schemes.

Authors:  Shivani Kumar; Robba Rai; Alto Stemmer; Sonal Josan; Lois Holloway; Shalini Vinod; Daniel Moses; Gary Liney
Journal:  Br J Radiol       Date:  2017-09-13       Impact factor: 3.039

Review 2.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

Review 3.  PET/MRI attenuation estimation in the lung: A review of past, present, and potential techniques.

Authors:  Joseph Lillington; Ludovica Brusaferri; Kerstin Kläser; Karin Shmueli; Radhouene Neji; Brian F Hutton; Francesco Fraioli; Simon Arridge; Manuel Jorge Cardoso; Sebastien Ourselin; Kris Thielemans; David Atkinson
Journal:  Med Phys       Date:  2020-01-01       Impact factor: 4.071

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.